Further exploration of the molecular mechanism by which CCNA2 modulates ccRCC progression revealed that the protein expression levels of N-cadherin, β-catenin and Vimentin were decreased by siCCNA2 (Fig. S6C). This evidence concerns the gene CCNA2 and nonpapillary renal cell carcinoma.